Saturday, 31 October 2026European Markets

JACQUET METALS, ALTRI SGPS, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - jacquet metals (jcq.pa) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
jacquet metals (jcq.pa) €18.42 5.5% 8.1%
altri sgps (altr.ls) €5.11 5.26% 12.9%
solvac nom(retail) (solv.br) €109.00 4.47% 11.29%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. jacquet metals (jcq.pa)

5.5% forward dividend yield and 8.1% return on equity

jacquet metals sa engages in the buying and trading of special metals in france, europe, asia, and north america. it operates through three divisions: jacquet, stappert, and ims group. the company distributes stainless-steel quarto plates, which are used in water, environment, energy, mechanical and forged metal construction, chemical and agri-food, gas processing and storage, pharmaceutical, and cosmetic sectors. it also distributes long stainless-steel products in the form of bars, profiles, welded tubes, and fittings that are used in the agri-food, chemical, petrochemical, pipefitting, energy, transport, and decoration sectors. in addition, the company distributes carbon, alloy, and stainless-steel engineering steels, and tool steels used in mechanical engineering, public works machinery, agricultural machinery, lifting machinery, car and hgv suppliers, and energy sectors. jacquet metals sa was founded in 1962 and is based in saint-priest, france.

earnings per share

as for profitability, jacquet metals has a trailing twelve months eps of €3.03.

pe ratio

jacquet metals has a trailing twelve months price to earnings ratio of 6.08. meaning, the purchaser of the share is investing €6.08 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.1%.

volatility

jacquet metals's last week, last month's, and last quarter's current intraday variation average was 0.08%, 0.07%, and 0.89%.

jacquet metals's highest amplitude of average volatility was 0.58% (last week), 1.09% (last month), and 0.89% (last quarter).

dividend yield

as maintained by morningstar, inc., the next dividend payment is on jul 5, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 5.5%.

volume

today's last reported volume for jacquet metals is 9668 which is 0.61% below its average volume of 9728.

moving average

jacquet metals's value is higher than its 50-day moving average of €18.18 and higher than its 200-day moving average of €17.68.

more news about jacquet metals.

2. altri sgps (altr.ls)

5.26% forward dividend yield and 12.9% return on equity

altri, sgps, s.a. produces and sells cellulosic fibers and energy in portugal and internationally. the company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. it is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. the company was incorporated in 2005 and is headquartered in porto, portugal.

earnings per share

as for profitability, altri sgps has a trailing twelve months eps of €0.21.

pe ratio

altri sgps has a trailing twelve months price to earnings ratio of 24.36. meaning, the purchaser of the share is investing €24.36 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.9%.

volume

today's last reported volume for altri sgps is 228632 which is 37.03% below its average volume of 363137.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, altri sgps's stock is considered to be overbought (>=80).

volatility

altri sgps's last week, last month's, and last quarter's current intraday variation average was a negative 1.21%, a positive 0.61%, and a positive 1.04%.

altri sgps's highest amplitude of average volatility was 1.21% (last week), 1.14% (last month), and 1.04% (last quarter).

sales growth

altri sgps's sales growth is negative 29.3% for the ongoing quarter and 244% for the next.

more news about altri sgps.

3. solvac nom(retail) (solv.br)

4.47% forward dividend yield and 11.29% return on equity

solvac s.a. operates as an advanced materials and specialty chemicals company in belgium. it offers specialty polymers, composite materials, soda ash, peroxides, silica, and coatis. the company was incorporated in 1983 and is headquartered in brussels, belgium.

earnings per share

as for profitability, solvac nom(retail) has a trailing twelve months eps of €19.

pe ratio

solvac nom(retail) has a trailing twelve months price to earnings ratio of 5.74. meaning, the purchaser of the share is investing €5.74 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.29%.

more news about solvac nom(retail).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com